Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Emergent BioSolutions Inc.

Complete the expansion project at the Rockville facility

Delivered by the deadline

Under re-examination This entry has been challenged and is being re-checked against the sources.

Announced
1 Aug 2022
Due
31 Dec 2022
Delivered
Q4 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The Company anticipates completing this expansion project by year end 2022.”

What we found

Evidence strength A What the grades mean

Emergent's Rockville facility expansion was completed in 2021, well before the 2022 year-end deadline stated in the August 2022 announcement.

  • A
    Emergent BioSolutions Inc. - Form 8-K - FY2022 Regulatory filing · published 31 Oct 2022 · retrieved 3 Oct 2026 · kept permanently by the SEC · fingerprint 06eddc8338d2
    “The Company anticipates completing this expansion project by year end 2022.” ✓ confirmed on the page
  • B
    Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022 Company website · published 27 Feb 2023 · retrieved 3 Oct 2026 · fingerprint a7f10903c048
    “For Q4 2022, gross capital expenditures decreased largely due to lower spending associated with the expansion project at the Company's Rockville facility, which was completed in 2021.” not found on the page

Checked 3 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Construction
Indicative materiality
Medium rules
Action
Complete
Deliverable
Rockville facility expansion
Where
Rockville
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Emergent BioSolutions Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2022-EBS-002477 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.